Search

everythinglearnresearchcommunity

for

Search:↓

A new compound shows promise as a topical treatment for hair loss.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Imatinib can cause hair loss due to lichen planopilaris.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Tofacitinib helped a woman regrow hair with no major side effects.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

The rash resolved after stopping ponatinib.

QLT0267 stops hair follicle cell growth and movement.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Nilotinib may cause gray hair to return to its original color.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.